Alector (ALEC) Retained Earnings (2018 - 2026)
Alector's (ALEC) quarterly Retained Earnings came in at -$1.0 billion in Q2 2026, down 204.82% year-over-year from $971.2 million in Q2 2025, and down 201.24% quarter-over-quarter from $1.0 billion in Q1 2026.
Analysis
Alector (ALEC) Retained Earnings (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Retained Earnings for 9 consecutive years, with -$1.0 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Retained Earnings fell 204.82% year-over-year to -$1.0 billion in Q2 2026; TTM through Jun 2026 was -$1.0 billion, a 204.82% decrease from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 4.9% from the prior year.
- Retained Earnings was -$1.0 billion for Q2 2026 at Alector, down from $1.0 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $1.0 billion in Q1 2026 and troughed at -$1.0 billion in Q2 2026.
- A 5-year average of $784.0 million and a median of $884.8 million in 2023 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings increased 14.15% in 2024 and tumbled 204.82% in 2026, its largest moves.
- Over 5 years, Retained Earnings stood at $798.7 million in 2022, then grew by 5.68% to $844.0 million in 2023, then rose by 13.22% to $955.7 million in 2024, then advanced by 4.9% to $1.0 billion in 2025, then plunged by 201.54% to -$1.0 billion in 2026.
- The last three Retained Earnings figures came in at -$1.0 billion (Q2 2026), $1.0 billion (Q1 2026), and $1.0 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | -22.28 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 9.53 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 15.69 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 37.62 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 558.00 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 5.10 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | -6.33 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 20.97 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | -1.02 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.02 Bn |
| Mar 31, 2026 | 1.01 Bn |
| Dec 31, 2025 | 1.00 Bn |
| Sep 30, 2025 | 992.29 Mn |
| Jun 30, 2025 | 971.19 Mn |
| Mar 31, 2025 | 964.01 Mn |
| Dec 31, 2024 | 955.66 Mn |
| Sep 30, 2024 | 945.05 Mn |
| Jun 30, 2024 | 936.01 Mn |
| Mar 31, 2024 | 925.46 Mn |
| Dec 31, 2023 | 844.04 Mn |
| Sep 30, 2023 | 831.91 Mn |
| Jun 30, 2023 | 821.85 Mn |
| Mar 31, 2023 | 810.75 Mn |
| Dec 31, 2022 | 798.70 Mn |
| Sep 30, 2022 | 787.10 Mn |
| Jun 30, 2022 | 775.84 Mn |
| Mar 31, 2022 | 762.46 Mn |
| Dec 31, 2021 | 748.04 Mn |
| Sep 30, 2021 | 726.69 Mn |